Clinical trial · Expanded Access
A Compassionate Use (CU) Program of Odronextamab
NCT05619367CI-TRIAL-00099515availableClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Provide compassionate use of odronextamab
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| B-Cell Non-Hodgkin Lymphoma (NHL) | B-Cell Non-Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.85 |
| Diffuse Large B-Cell Lymphoma (DLBCL) | Diffuse Large B-Cell Lymphoma | ALIAS | 0.90 |
| High-Grade B-Cell Lymphoma (HGBCL) | High Grade B-Cell Lymphoma | CURATED_BROADER | 0.80 |
| Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Odronextamab | Drug | Odronextamab | ALIAS |
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility record
- sex
- ALL
- stdAges
- CHILD
- ADULT
- OLDER_ADULT
- criteria
- null
- maximumAge
- null
- minimumAge
- null
- healthyVolunteers
- null
References
Publications (0)
Data not yet available
No reference posted for this study.